Study Confirms Minimally-Invasive Pulmonx Therapy Effectively Treats Emphysema
- Posted by Chris Kellett
- On September 25, 2011
September 25, 2011, Amsterdam, Netherlands (ERS) – Pulmonx Inc. has just announced final results of its Chartis multi-centre study1, presented today at the European Respiratory Society’s 2011 Congress. This definitive data confirms that use of the Chartis® Pulmonary Assessment System to plan Zephyr® valve treatmentsis the key to successful EBV treatment of emphysema.
Read More